NEW YORK, NY, Feb. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a...
KELOWNA, British Columbia, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied") (OTCQB: ALID) – an international medical company focused...
Company Pursuing Development of PAX-101 as Treatment for Autism Spectrum Disorder and Other Neurodevelopmental Conditions WOODCLIFF LAKE, N.J., Feb. 02,...
New York, New York, Feb. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- EncrypGen, the world’s first blockchain-mediated genomic DNA...
Vancouver, Feb. 02, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...
SAN CARLOS, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. a leader in the development of comprehensive solutions for...
HAIFA, Israel, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a...
NeurMedix Expects to Enroll the First Patient in May 2021SAN DIEGO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- NeurMedix, LLC, a...
- Patients’ Cognition Improved 1.6 Points on ADAS-Cog11 -- Patients’ Behavior Improved 1.3 Points on NPI - - Improvements Maintained...
REDWOOD CITY, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- A day after announcing their new immuno-oncology collaboration, Coherus BioSciences, Inc. (Nasdaq:...
MINNEAPOLIS, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”)...
Two positive events in January support PMN310 “best in class” positioning TORONTO and CAMBRIDGE, Mass., Feb. 02, 2021 (GLOBE NEWSWIRE)...
DENVER, CO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business cannabis...
CHK-336 On Track for Phase 1 Clinical Trial Initiation in the Second Half of 2021 VANCOUVER, British Columbia and SEATTLE,...
LA JOLLA, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL) today embarks on a collaboration with researchers from...
$7 Million in Annualized Revenues, in Excess of 15% Adjusted EBITDA Margin and Increases Protech’s Active Patient Count by More Than...
Customers rank R1 as Best in KLAS® in prestigious annual survey CHICAGO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- R1 RCM...
If Approved for Clearance, Vivos’ Updated Device Will Treat Mild to Moderate Sleep Apnea and Expand Insurance Reimbursement to include...
NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the...
D-dimer levels have been correlated with disease severity and risk of mortality in patients with COVID-19Treatment with Auxora improved D-dimer...